Atıf İçin Kopyala
Weniger M., Moir J., Damm M., Maggino L., Kordes M., Rosendahl J., ...Daha Fazla
Surgical oncology, cilt.35, ss.285-297, 2020 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
35
-
Basım Tarihi:
2020
-
Doi Numarası:
10.1016/j.suronc.2020.08.031
-
Dergi Adı:
Surgical oncology
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Agricultural & Environmental Science Database, EMBASE, MEDLINE
-
Sayfa Sayıları:
ss.285-297
-
Anahtar Kelimeler:
Neoadjuvant chemotherapy, Survival, Advanced age, SURVIVAL
-
Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli:
Evet
Özet
Introduction: The number of people aged 60 and above will rise from 46 million in 2015 to 157 in 2050 million, exceeding 30% of the population in many western countries. Consequently, the demand for oncological therapy for elderly patients will increase within the next decades. Currently, sufficient data on neoadjuvant therapy (NTx) of pancreatic cancer in elderly patients are lacking.